4 ms·
It's unfortunate that regulatory environment in the US is not more favorable for advancing phage therapy. It could be a promising alternative to antibiotics for
by tomkinstinch 14y ago
It's unfortunate that regulatory environment in the US is not more favorable for advancing phage therapy. It could be a promising alternative to antibiotics for treating infections caused by multi-drug resistant organisms.
- breakyerself 14y agoFrom what I've read. You're probably right. They're worried that mutations make it hard to lock down the exact properties of any given phage treatment, but that would be a risk I'd be willing to take. Especially since they're in wide use in some countries with no horror stories that I've heard.